02380 408 600 Contact us Book a course

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

Menu

×

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997

Post navigation

Previous: Montelukast and improvement of eczema: observations from a prescription event monitoring study in England

Next: The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies

Interested in conducting a study?

Get in touch today to discuss your requirements

Services

Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training

Information

Publications
DSRU News
Press
General Practitioners
Conference Abstracts

Organisation

About Us
Meet The Team
Job Vacancies
Privacy Policy
Terms & Conditions

© 2023 DSRU - Bursledon Hall, Blundell Lane, Southampton, SO31 1AA | Registered Charity No. 327206 | Designed & developed by Dolia